Skip to main content
. 2017 Oct 13;7:13128. doi: 10.1038/s41598-017-13385-1

Table 4.

Association between the SNPs and IIM with ILD.

Disease Group rs6590330 rs7117932 rs4937362
Pc OR (95%CI) Pc OR (95%CI) Pc OR (95%CI)
DM P vs. N NS 1.10(0.87–1.38) NS 1.11(0.87–1.41) NS 1.10(0.87–1.40)
P vs. C 0.031 1.24(1.05–1.47) 8.90 × 10 −3 1.31(1.10–1.56) NS 0.94(0.79–1.12)
N vs. C 0.63 1.13(0.93–1.38) 0.35 1.18(0.96–1.46) 0.41 0.86(0.70–1.05)
PM P vs. N NS 0.90(0.66–1.21) NS 0.99(0.71–1.37) 0.91 0.85(0.61–1.17)
P vs. C 0.82 1.13(0.91–1.41) NS 1.13(0.89–1.43) 0.16 0.78(0.61–0.99)
N vs. C 0.16 1.26(1.00–1.59) 0.95 1.14(0.88–1.47) NS 0.92(0.72–1.18)
IIM P vs. N NS 1.02(0.85–1.22) NS 1.07(0.88–1.30) NS 1.00(0.83–1.22)
P vs. C 0.034 1.20(1.04–1.39) 0.016 1.24(1.07–1.45) 0.35 0.89(0.76–1.03)
N vs. C 0.13 1.18(1.00–1.39) 0.26 1.16(0.98–1.38) 0.41 0.88(0.74–1.04)

Bold values are statistically significant (P < 0.05) (corrected for multiple comparisons by the Bonferroni adjustment test). DM: dematomyositis; PM: polymyositis; IIM: idiopathic inflammatory myopathies; ILD: interstitial lung disease; Group P: patients with ILD; Group N: patients without ILD; Group C: Healthy controls; Pc: P value corrected by Bonferroni method. Group P (DM: n = 390; PM: n = 195; IIM: n = 585); Group N (DM: n = 264; PM: n = 168; IIM: n = 432); Group C (n = 1280).